ACBD3 and prostate cancer: To this end, five human cell lines including HeLa-S3, human lung cancer cell A549, human prostate cancer cell DU145, human hepatoma HepG2 and human osteosarcoma U-2 OS were treated with shRNA lentivirus to stably knock down ACBD3.